Sen. Josh Hawley (R-MO) said Friday that he believes Food and Drug Administration Commissioner Marty Makary “misled” him regarding his commitment to President Donald Trump’s anti-abortion agenda after the agency approved a new generic version of an abortion pill.
Hawley was one of the first senators on Thursday to criticize the FDA for approving the new generic version of the pill mifepristone, which will be produced by the company Evita Solutions. He said he has “lost confidence” in the agency.
Real journalism.Trusted by millions.
Unlimited access to in-depth reporting, expert analysis, and the stories that shape our country.
Subscribe Now
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.